Dr Ian Gilham
Ian is an experienced CEO and Chairman of life sciences companies. He is currently Chairman of Genedrive plc (listed on AIM) and Cytox Limited. From 2014-2021 he was Chairman of Horizon Discovery Group plc before its recent sale to Perkin Elmer, Inc. From 2008 to 2011 he was CEO of Axis-Shield plc, a main market listed global diagnostics company that was sold to Alere Inc. for £260 million in 2011. Ian previously worked at GlaxoSmithKline as Vice President – Pharmacogenetics and previously held international general management, marketing, business development and R&D positions with Abbott Laboratories. Ian served as Chairman of Multiplicom N.V. between 2013 and it’s sale to Agilent in 2017. He holds a life sciences Ph.D. from the University of Bath and a degree in zoology from the University of Wales.
Ian Chairs the Remuneration Committee.